No New Trial for the 3rd Xarelto Bellwether Plaintiff
No New Trial for the 3rd Xarelto Bellwether Plaintiff
Introduction
The plaintiff of the 3rd Xarelto bellwether trial, which went in favor of the Xarelto defendants J&J's Janssen Pharmaceuticals and Bayer in August 2017, faced a defeat again when a Louisiana federal judge turned down the request for a new trial.
The plaintiff had planned for a retrial based on the recent scientific study that she hoped could change the jury's mind. Judge Eldon E. Fallon denied her request stating that the newly discovered evidence was actually cumulative of the previously known and admitted evidence.
Xarelto lawsuits are consolidated under MDL No.- 2592 in the U.S. District Court for the Eastern District of Louisiana; nearly 22,000 cases are a part of this MDL while more than 1,500 cases are pending in Philadelphia's Complex Litigation Center.
Comments
Latest News
Walgreens Settles Federal Opioid Case for $300 Million
Categories: Opioids
Walgreens has agreed to pay $300 million to settle allegations by U.S. prosecutors that it unlawfully filled millions of invalid prescriptions for opioids and other controlled substances.
The U.S. Department of Justice announced on Monday…
Study: Opioid Use in Pregnancy May Shrink Newborn Brains
Categories: Opioids
New research from Children’s National Hospital in Washington, D.C., reveals that infants exposed to opioids in the womb have significantly smaller brain volumes than…
Suboxone Tooth Loss Lawsuits Reviewed at MDL Meeting
Categories: Opioids
The U.S. District Judge overseeing the federal Suboxone tooth decay multidistrict litigation (MDL) is scheduled to meet with attorneys tomorrow to assess the progress of pretrial proceedings and strategize on resolving over 11,000 product…